Despite similar half-lives, retatrutide (6 days), tirzepatide (5 days), and semaglutide (7 days) all support once-weekly dosing
Published research literature most frequently references Ipamorelin in models examining pulsatile growth hormone release, ghrelin/GHS receptor signalling, endocrine-axis pharmacology, comparator studies versus less-selective GH secretagogues (GHRP-2, GHRP-6, hexarelin), and combination research with GHRH analogues like CJC-1295
The Bottom Line PT-141 is a prescription drug that can increase sex drive in both men and women
Novo Nordisk faces patent challenges, biosimilar development, and rival medications
There are specific safety issues that should be considered carefully, especially regarding interactions with lupus treatments and the risk of side effects